International Niemann–Pick Disease Alliance
CTD Holdings Enrolls First Patient in European Phase I/II Clinical Trial of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C Company Expects Final Data from Trial by End of 2018 Alachua, FL – (Marketwired) – June 21, 2017...
The Annual VML Members’ Weekend was held from Friday 26 May to Sunday 28 May 2017 at the Domaine de Chalès in Nouan-le-Fuzelier (41) France – as ever it was an occasion filled with fun as the community came...
CTD Holdings Announces Appointments of Two Patient Liaisons to Enhance Outreach to Niemann-Pick Disease Type C Families and Caregivers Liaisons to Provide Counsel to Patient Families Around Recently Initiated Phase I and Phase I/II Clinical Trials ALACHUA, FL –...
The Pactimo online charity shop, which seeks to support the International Niemann-Pick Disease Alliance (INPDA), is now open! Summer is almost in full swing so why not have a look at our biking suits or sports T-shirts for either...
(Available for Download in English, German, French, Spanish, Italian, and Polish) Interim Information Bulletin SUMMARY 002 Study: All patients have now started treatment with study medicine Orphazyme to present at Spanish NPC Association on June 24th The...
The 21st Niemann-Pick Sielbstilfegruppe family support meeting took place in Kassel last weekend on Saturday 27th May. This was the 17th year that it has been held in the same location, one ideally positioned in the geographical centre of...
Download Here Opportunity for Patients, Families, and Caregivers to Hear Additional Details on Recently Initiated Phase I and Phase I/II Clinical Trials ALACHUA, FL — (Marketwired — May 16, 2017) — CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage...
ORPHAZYME COMPLETES ENROLMENT OF PATIENTS FOR PHASE 3 CLINICAL TRIAL IN NIEMANN-PICK TYPE C DISEASE Copenhagen, 11 May 2017 Download Here Orphazyme ApS, a Danish biotech company developing novel therapies for the treatment of protein misfolding diseases, today announced...
Update #15 on the AIDNPC clinical programme (arimoclomol in treatment of Niemann-Pick disease type C) Conference call with patient organizations (30 MAR ’17) Available for download in English, French, German, Italian, Polish, and Spanish SUMMARY 002 Study:...
Available for Download ALACHUA, FL – (Marketwired) – March 23, 2017 – CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, today announced that it has begun recruiting patients...